Barriers to quality of life in patients with multiple sclerosis: a qualitative study

Por Zahra Hosseini, Atefeh Homayuni, Masoud Etemadifar
Publicado em 2022-05-01

The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population

Por Morteza Abdar, Payam Ebrahimifar, Masoud Etemadifar
Publicado em 2017-03-01

Fingolimod versus High Dose Interferon Beta-1a in Multiple Sclerosis: A Randomized Clinical Trial

Por Masoud Etemadifar, Pedram Moeini, Seyed-Masoud Nabavi
Publicado em 2017-02-01

Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis

Por Ahmad Chitsaz, Noushin Mehrbod, Masoud Etemadifar, Mohamadreza Najafi
Publicado em 2013-01-01

The Relationship between Cognitive Disorders and Hippocampal Angle in Patients Multiple Sclerosis

Por Azin Shayganfar, Masoud Etemadifar, Nafiseh Nasr, Shokoufeh Mousavi
Publicado em 2019-09-01

Late cardiotoxicity in MS patients treated with mitoxantrone

Por Jamshid Najafian, Ali Nasri, Masoud Etemadifar, Fardin Salehzadeh
Publicado em 2019-01-01

The effect of eight-week Pilates training on motor function and depression in subjects with Multiple Sclerosis (MS)

Por Zohreh Mohamadi Dinani, Maryam Nezakatolhossaini, Fahimeh Esfarjani, Masoud Etemadifar
Publicado em 2013-06-01

Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study

Por Nasim Tabrizi, Masoud Etemadifar, Fereshteh Ashtari, Arash Zahed, Fatemeh Etemadifar
Publicado em 2012-01-01

Vitamin D: Shining a light on clinical and sex specific effects in multiple sclerosis?

Por Mahboobeh Fereidan-Esfahani, Sreeram V Ramagopalan, Masoud Etemadifar, Soroush Sadri, Seyed-Hossein Abtahi
Publicado em 2013-01-01

A Case-Control Study on Risk Factors in Pediatric Multiple Sclerosis Population, Isfahan Province, Iran: Highlighting the Role of Puberty

Por Masoud Etemadifar, Pedram Moeini, Sanaz Masoumi, Amin Bagheri-Ghalehsalimi, Ali Alavi, Mahboobeh Fereidan-Esfahani
Publicado em 2017-05-01

The Frequency of TIM-3-1541C>T Polymorphisms and its Association with Multiple Sclerosis

Por Fariba Mazrouei, Mazdak Ganjalikhani-Hakemi, Rasoul Salehi, Fereshteh Ale-Sahebfosoul, Masoud Etemadifar, Hamid Zarkesh-Esfahani
Publicado em 2015-07-01

Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study

Por Masoud Etemadifar, Mojtaba Kazemi, Ahmad Chitsaz, Ali Hekmatnia, Nazila Tayari, Amirhossein Ghazavi, Amir Hadi Maghzi
Publicado em 2011-01-01

Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran

Por Masoud Etemadifar, Hamidreza Jahanbani Ardakani, Sara Ghaffari, Mahboobeh Fereidan-Esfahani, Hossein Changaei, Nazila Aghadoost, Ameneh Jahanbani-Ardakani, Negin Moradkhani
Publicado em 2017-06-01

Hemiballismus, Hyperphagia, and Behavioral Changes following Subthalamic Infarct

Por Masoud Etemadifar, Seyed-Hossein Abtahi, Seyed-Mojtaba Abtahi, Motahreh Mirdamadi, Sepideh Sajjadi, Aryan Golabbakhsh, Mohammad-Reza Savoj, Mahboobeh Fereidan-Esfahani, Zahra Nasr, Nasim Tabrizi
Publicado em 2012-01-01